G. Heinzel

发表

Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam.

D. Türck, G. Heinzel, G. Luik, 2000, British journal of clinical pharmacology.

Pharmacokinetics and tolerability of meloxicam after i.m. administration.

H. Narjes, G. Nehmiz, D. Türck, 1996, British journal of clinical pharmacology.

Effect of Food on the Pharmacokinetics of Meloxicam after Oral Administration

H. Narjes, G. Nehmiz, D. Türck, 1995 .

Clinical pharmacokinetics of meloxicam.

H. Narjes, D. Türck, U. Busch, 1997, Arzneimittel-Forschung.

Pharmacokinetics of Meloxicam in Patients with Hepatic Cirrhosis in Comparison with Healthy Volunteers

H. Narjes, G. Nehmiz, D. Türck, 1996 .

Lack of interaction between meloxicam and warfarin in healthy volunteers

E. Bluhmki, D. Türck, U. Busch, 2009, European Journal of Clinical Pharmacology.

Kinetics of biosynthetic human proinsulin in patients with terminal renal insufficiency.

C. Hales, P. Bottermann, K. Wahl, 1988, Hormone and metabolic research. Supplement series.

Pharmacokinetics of biosynthetic human proinsulin following intravenous and subcutaneous administration in metabolically healthy volunteers.

C. Hales, P. Bottermann, K. Wahl, 1988, Hormone and metabolic research. Supplement series.

Pharmacokinetics of meloxicam in patients with end-stage renal failure on haemodialysis: a comparison with healthy volunteers

A. Schwarz, D. Höffler, H. Narjes, 1996, European Journal of Clinical Pharmacology.

Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. II: Pharmacodynamics.

U. Gundert-Remy, P. Hinderling, O. Schmidlin, 1985, Journal of pharmaceutical sciences.

Comparative cardiac toxicity of the i.v. administered benzimidazole pyridazinon derivative Pimobendan and its enantiomers in female Beagle dogs.

G. Trieb, H. Von Nicolai, G. Heinzel, 1997, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Precision of measurement of tissue concentrations by RLG.

G. Nehmiz, U. Busch, G. Heinzel, 2000, Regulatory toxicology and pharmacology : RTP.

Disposition and chemical stability of telmisartan 1-O-acylglucuronide.

T. Ebner, G. Heinzel, H. Wachsmuth, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Amino acid kinetics in patients with sepsis.

W. Druml, G. Kleinberger, G. Heinzel, 2001, The American journal of clinical nutrition.

The pharmacokinetics and metabolism of mitoxantrone in man

G. Ehninger, B. Proksch, D. Woodward, 2004, Investigational New Drugs.

Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-γ in cancer patients

W. Digel, F. Porzsolt, G. Heinzel, 2005, Cancer Immunology, Immunotherapy.

Meloxicam pharmacokinetics in renal impairment.

G. Nehmiz, D. Türck, J. Boulton-Jones, 1997, British journal of clinical pharmacology.

Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.

U. Busch, G. Heinzel, J. Schmid, 1995, Drug Metabolism And Disposition.

Clinical pharmacology of mitoxantrone.

G. Ehninger, B. Proksch, D. Woodward, 1986, Cancer treatment reports.

Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects.

J. Jonkman, W. Roth, E. Bauer, 1993, Journal of pharmaceutical sciences.

Pharmacokinetics of meloxicam in animals and the relevance to humans.

U. Busch, W. Roth, G. Heinzel, 1998, Drug metabolism and disposition: the biological fate of chemicals.

The effect of meloxicam on the pharmacokinetics of beta-acetyl-digoxin.

H. Narjes, D. Türck, F. Degner, 1995, British journal of clinical pharmacology.

[Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)].

G. Heinzel, F. Koss, G. Bozler, 1977, Arzneimittel-Forschung.

Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.

P. Tanswell, G. Heinzel, J. Krause, 1990, The Journal of pharmacology and experimental therapeutics.

The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man

H. Narjes, U. Busch, G. Heinzel, 2004, European Journal of Clinical Pharmacology.

Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.

P. Tanswell, G. Heinzel, J. Krause, 1990, The Biochemical journal.

Effect of food on pharmacokinetics of meloxicam, a new non steroidal anti-inflammatory drug (NSAID)

H. Narjes, U. Busch, G. Heinzel, 2005, Agents and Actions.

Model building in pharmacokinetics/Part V: Simulation of blood level curves following repetitive dosing and their experimental verification (author's transl).

G. Heinzel, F. Koss, G. Bozler, 1977, Arzneimittel-Forschung.

Absorption of lefradafiban from different sites of the gastrointestinal tract.

C. Beglinger, J. Drewe, H. Narjes, 2000, British journal of clinical pharmacology.